Form D · Biotechnology
ENDO Medical, Inc.
San Francisco, CA · CIK 0001676914
Offering snapshot reported Jun 15, 2016 · SEC filing
- Reported sold
- $440K Offering amount: $2.94M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 13, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2016 | Initial | $440,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-265138
Promissory notes convertible into equity securities of the Issuer
Source: Form D, filed Jun 15, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Apostolos Atsalakis | Director, Promoter |
| Sarah Lerche | Executive |
| Panagiotis Papadiamantis | Director, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2235 3 Rd Street, Unit E406
San Francisco, CA, 94107
San Francisco, CA, 94107